Pharmaceuticals

Chorionic Gonadotropin Market Outlook 2026–2030: Key Business Drivers and Trends

March 5, 2026March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the chorionic gonadotropin market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Chorionic Gonadotropin Market show for the 2026–2030 period?

The chorionic gonadotropin market has experienced substantial expansion in recent years. Projections indicate its growth from $1.34 million in 2025 to $1.43 million in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. This historical growth can be attributed to factors such as the increasing prevalence of infertility treatments, its established role in ovulation induction, the rise in male reproductive disorders, the implementation of hospital based fertility programs, and its long standing clinical usage.

The chorionic gonadotropin market is projected for substantial expansion in the coming years, with its size anticipated to reach $1.82 million by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. This anticipated growth during the forecast period stems from several factors, including the global increase in infertility rates, the proliferation of assisted reproductive technologies, a heightened understanding of male hormonal imbalances, the expanded use in oncology diagnostics, and improved access through retail pharmacies. Key developments expected during this period involve the increased adoption in assisted reproductive treatments, a broader application in therapies for male hypogonadism, a surge in demand for fertility hormone treatments, the wider utilization as a tumor marker in diagnostics, and advancements in formulations leading to more precise dosages.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp

What Drivers Are Shaping The Development Of The Chorionic Gonadotropin Market?

The rising occurrence of infertility challenges is anticipated to stimulate the expansion of the chorionic gonadotropin market. Infertility is characterized as the inability to achieve conception after a year of regular, unprotected sexual activity for couples under 35, or after six months for those aged 35 and above. The increasing prevalence of infertility primarily stems from delayed childbearing, as many choose to have children later in life, alongside lifestyle factors like obesity and smoking, which can adversely affect reproductive health. Chorionic Gonadotropin (hCG) is utilized in fertility treatments to trigger ovulation in women, support the luteal phase for pregnancy maintenance, and boost testosterone production in men to improve sperm count, addressing diverse infertility issues. For example, in April 2023, the World Health Organization (WHO), a specialized agency based in Switzerland, indicated that around 17.5% of the adult global population, or 1 in 6 people, experiences infertility, emphasizing the critical necessity to enhance access to affordable, high-quality fertility care for affected individuals. Therefore, the increasing prevalence of infertility issues is a key factor propelling the chorionic gonadotropin market’s growth.

Which Segments Are Contributing To The Growth Of The Chorionic Gonadotropin Market?

The chorionic gonadotropin market covered in this report is segmented –

1) By Type: Human Chorionic Gonadotropin, Animal Chorionic Gonadotropin

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Therapeutic Application: Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment, Chronic Pain, Other Therapeutic Applications

4) By End User: Research Institutions, Pharmaceutical Companies

Which Market Trends Are Opening Growth Opportunities In The Chorionic Gonadotropin Market?

Major companies operating in the chorionic gonadotropin market are focusing on developing innovative solutions, such as saliva-based pregnancy tests, to improve convenience, accuracy, and accessibility. A saliva-based pregnancy test refers to a non-invasive diagnostic method that detects pregnancy by analyzing a woman’s saliva for the presence of human chorionic gonadotropin (hCG), a hormone produced during pregnancy. For instance, in June 2023, Salignostics, an Israel-based biotech company, launched as the world’s first saliva-based pregnancy test. This innovative product allows women to determine pregnancy using a saliva sample instead of urine, detecting the hormone hCG (human chorionic gonadotropin) with results available in just 5 to 15 minutes. Salistick offers a more comfortable and convenient testing experience, enabling users to test anywhere and share the moment with partners or loved ones.

Who Are The Major Companies Operating In The Chorionic Gonadotropin Market?

Major companies operating in the chorionic gonadotropin market are Ferring Pharmaceuticals

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Chorionic Gonadotropin Market?

North America was the largest region in the chorionic gonadotropin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Chorionic Gonadotropin Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19888&type=smp

Browse Through More Reports Similar to the Global Chorionic Gonadotropin Market 2026, By The Business Research Company

Human Chorionic Gonadotropin Market Report 2026

https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report

Gonadotropin Releasing Hormone Gnrh Agonist Market Report 2026

https://www.thebusinessresearchcompany.com/report/gonadotropin-releasing-hormone-gnrh-agonist-global-market-report

Male Hypogonadism Market Report 2026

https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795